Dr. Joe Mendez, MD
Claim this profileHuntsman Cancer Institute/University of Utah
Studies Glioblastoma
Studies Brain Tumor
11 reported clinical trials
20 drugs studied
Area of expertise
1Glioblastoma
IDH negative
MET positive
MET negative
2Brain Tumor
H3 K27M positive
Stage IV
H3
Affiliated Hospitals
Clinical Trials Joe Mendez, MD is currently running
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Joe Mendez, MD
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Joe Mendez, MD has experience with
- ONC201
- Nivolumab
- Ipilimumab
- Tirabrutinib
- Radiation Therapy
- Stereotactic Radiosurgery
Breakdown of trials Joe Mendez, MD has run
Glioblastoma
Recurrence
Mesial Temporal Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joe Mendez, MD specialize in?
Joe Mendez, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is Joe Mendez, MD currently recruiting for clinical trials?
Yes, Joe Mendez, MD is currently recruiting for 7 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Joe Mendez, MD has studied deeply?
Yes, Joe Mendez, MD has studied treatments such as ONC201, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Joe Mendez, MD?
Apply for one of the trials that Joe Mendez, MD is conducting.
What is the office address of Joe Mendez, MD?
The office of Joe Mendez, MD is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.